Activating KIR copy number variation is associated with granzyme B release by NK cells during primary simian immunodeficiency virus infection in rhesus monkeys

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 13103-13107

  Hellmann, Ina ^a   Schmitz, Jörn E ^a   Letvin, Norman L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD8ALPHA ANTIGEN; GRANZYME B; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2A; PERFORIN;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOLYSIS; ENZYME RELEASE; GENE; GEOMETRIC MEAN OF THE FLUORESCENCE INTENSITY; IN VITRO STUDY; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DH GENE; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALS; GENE DOSAGE; GRANZYMES; KILLER CELLS, NATURAL; MACACA MULATTA; RECEPTORS, KIR; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84869229437     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00325-12     Document Type: Article

References (24)

1. Alter G, et al. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204: 3027-3036.
2. + NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 83:6798-6805.
3. Andersson LC, Nilsson K, Gahmberg CG. 1979. K562-a human erythroleukemic cell line. Int. J. Cancer 23:143-147.
4. Blokhuis JH, Doxiadis GG, Bontrop RE, 2008. A splice site mutation converts an inhibitory killer cell Ig-like receptor into an activating one. Mol. Immunol. 46:640-648.
5. Brandt CS, et al. 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206:1495-1503.
6. Cooper MA, Fehniger TA, Caligiuri MA. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
7. Duchler M, et al. 1995. NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur. J. Immunol. 25:2923-2931.
8. Hellmann I, Lim SY, Gelman RS, Letvin NL. 2011. Association of activating KIR copy number variation ofNKcells with containment of SIV replication in rhesus monkeys. PLoS Pathog. 7:e1002436. doi:10.1371/journal.ppat.1002436.
9. Hershberger KL, Shyam R, Miura A, Letvin NL. 2001. Diversity of the killer cell Ig-like receptors of rhesus monkeys. J. Immunol. 166:4380-4390.
10. Huntington ND, et al. 2009. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206:25-34.
11. Lee SH, et al. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:42-45.
12. Li H, Pascal V, Martin MP, Carrington M, Anderson SK. 2008. Genetic control of variegated KIR gene expression: polymorphisms of the bidirectional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet. 4:e1000254. doi:10.1371/journal. pgen.1000254.
13. Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS. 1981. A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166:546-550.
14. Lozzio CB, Lozzio BB. 1975. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321-334.
15. Martin MP, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434.
16. Pascal V, et al. 2007. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J. Immunol. 179:1625-1633.
17. Pelak K, et al. 2011. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol. 9:e1001208. doi:10.1371/journal.pbio.1001208.
18. Reading PC, Whitney PG, Barr DP, Smyth MJ, Brooks AG. 2006. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur. J. Immunol. 36:897-905.
19. Reeves RK, et al. 2010. CD16-natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115:4439-4446.
20. Sivori S, et al. 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. U. S. A. 99:4526-4531.
21. Sivori S, et al. 1999. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29:1656-1666.
22. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. 2008. Functions of natural killer cells. Nat. Immunol. 9:503-510.
23. Wabuke-Bunoti MA, Bennink JR, Plotkin SA. 1986. Influenza virusinduced encephalopathy in mice: interferon production and natural killer cell activity during acute infection. J. Virol. 60:1062-1067.
24. Webster RL, Johnson RP. 2005. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115:206-214.